Innovative approaches to irinotecan-based therapies for glioblastoma: Advancements in drug delivery and combination strategies.
Saved in:
| Title: | Innovative approaches to irinotecan-based therapies for glioblastoma: Advancements in drug delivery and combination strategies. |
|---|---|
| Authors: | Hsu CY; Department of Pharmacy, Chia Nan University of Pharmacy and Science, Tainan 71710, Taiwan. Electronic address: t545316@gmail.com., Baig MR; College of Pharmacy, Department of Pharmacy Practice, Dubai Medical University, Dubai, United Arab Emirates., Patel PN; Faculty of Pharmacy, Gokul Global University, Sidhpur, Gujarat, India., Singh G; Sharda School of Pharmacy, Sharda University, Greater Noida, India., Abdelrahim IM; Department of Microbiology and Clinical Parasitology, King Khalid University, Saudi Arabia., Kadhem M; College of Pharmacy, The Islamic University, Najaf, Iraq., Arora V; University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India., Maddula VR; Department of Pharmaceutical Sciences, Vignan's Foundation for Science, Technology and Research, Vadlamudi, Guntur, A.P., India., Nayak PP; Department of Medical Oncology, IMS and SUM Hospital, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India., Iqbal MS; Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, 11942, Alkharj, Saudi Arabia. |
| Source: | Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2026 Mar; Vol. 219, pp. 105144. Date of Electronic Publication: 2026 Jan 22. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
